Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents:an observational cohort study

Garelius, Hege Kristin Gravdahl, Bagguley, Timothy orcid.org/0000-0002-6150-3467, Taylor, Adele orcid.org/0000-0001-7793-8222 et al. (20 more authors) (2025) Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents:an observational cohort study. The Lancet Haematology. e128-e137. ISSN 2352-3026

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

Copyright © 2025 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Keywords: Humans,Quality of Life,Myelodysplastic Syndromes/drug therapy,Female,Male,Hematinics/therapeutic use,Aged,Middle Aged,Erythrocyte Transfusion/adverse effects,Registries,Aged, 80 and over,Cohort Studies,Longitudinal Studies
Dates:
  • Published: 3 February 2025
  • Accepted: 12 November 2024
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Health Sciences (York)
Depositing User: Pure (York)
Date Deposited: 11 Feb 2025 00:13
Last Modified: 13 Feb 2025 05:32
Published Version: https://doi.org/10.1016/S2352-3026(24)00350-8
Status: Published
Refereed: Yes
Identification Number: 10.1016/S2352-3026(24)00350-8
Open Archives Initiative ID (OAI ID):

Download

Filename: PIIS2352302624003508.pdf

Description: PIIS2352302624003508

Licence: CC-BY 2.5

Export

Statistics